Chordate Financial Statements From 2010 to 2024
| CMH Stock | 12.55 0.25 1.95% |
Check Chordate Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chordate Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Chordate financial statements analysis is a perfect complement when working with Chordate Medical Valuation or Volatility modules.
Chordate |
Chordate Medical Holding Company Current Valuation Analysis
Chordate Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Chordate Medical Current Valuation | 102.78 M |
Most of Chordate Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chordate Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Chordate Medical Holding has a Current Valuation of 102.78 M. This is 99.28% lower than that of the Healthcare sector and 99.17% lower than that of the Medical Devices industry. The current valuation for all Sweden stocks is 99.38% higher than that of the company.
Chordate Medical Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chordate Medical's current stock value. Our valuation model uses many indicators to compare Chordate Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chordate Medical competition to find correlations between indicators driving Chordate Medical's intrinsic value. More Info.Chordate Medical Holding is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chordate Medical's earnings, one of the primary drivers of an investment's value.About Chordate Medical Financial Statements
Chordate Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Chordate Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Chordate Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Chordate Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.